HYDROPANE Drug Patent Profile
✉ Email this page to a colleague
When do Hydropane patents expire, and when can generic versions of Hydropane launch?
Hydropane is a drug marketed by Halsey and is included in one NDA.
The generic ingredient in HYDROPANE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydropane
A generic version of HYDROPANE was approved as homatropine methylbromide; hydrocodone bitartrate by AVANTHI INC on August 7th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROPANE?
- What are the global sales for HYDROPANE?
- What is Average Wholesale Price for HYDROPANE?
Summary for HYDROPANE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | HYDROPANE at DailyMed |
US Patents and Regulatory Information for HYDROPANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Halsey | HYDROPANE | homatropine methylbromide; hydrocodone bitartrate | SYRUP;ORAL | 088066-001 | Jun 28, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
